Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan plus amoxicillin dual therapy for Helicobacter pylori infection
ChiCTR2300071997Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tegoprazan and amoxicillin in Helicobacter pylori infection (3 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Eradication rate of Helicobacter pylori. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
tegoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2300071997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071997.